EARLY ACCESS
Grade B Rct

Caloric Restriction and Epigenetic Age: CALERIE-2 Results

Analysis of CALERIE-2 trial examining 25% caloric restriction effects on epigenetic aging clocks over 2 years in non-obese adults.

Published 2023 19 views DOI: 10.1038/s43587-023-00345-y

[STUDY DETAILS]

Study Type
Rct
Quality Grade
B
Publication Year
2023

Summary

CALERIE-2 (n=220) found 25% caloric restriction slowed epigenetic aging by 2-3% per year measured by DunedinPACE clock. This translates to 10-15% reduced mortality risk.

Key Findings

1. Epigenetic aging slowed 2-3% annually
2. Estimated 10-15% mortality reduction
3. Benefits sustained over 2 years
4. No adverse effects on bone or muscle